Ansell Limited (ASX:ANN)
Australia · Delayed Price · Currency is AUD 26.25
+0.17 (0.63%)
May 22, 2026, 4:13 PM AEST
Ansell Market Cap
Ansell has a market cap or net worth of 3.64 billion as of May 21, 2026. Its market cap has decreased by -20.89% in one year.
Market Cap
3.64B
Enterprise Value
4.56B
Revenue
3.01B
Ranking
n/a
PE Ratio
18.73
Stock Price
26.25
Market Cap Chart
Since January 16, 1992, Ansell's market cap has decreased from 5.00B to 3.64B, a decrease of -27.08%. That is a compound annual growth rate of -0.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 21, 2026 | 3.64B | -26.97% |
| Dec 31, 2025 | 4.99B | 1.96% |
| Dec 31, 2024 | 4.89B | 56.70% |
| Dec 29, 2023 | 3.12B | -12.08% |
| Dec 30, 2022 | 3.55B | -11.25% |
| Dec 31, 2021 | 4.00B | -10.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 47.90B |
| Sigma Healthcare | 32.78B |
| Pro Medicus | 13.61B |
| Sonic Healthcare | 9.11B |
| Ramsay Health Care | 8.77B |
| Cochlear | 6.24B |
| Telix Pharmaceuticals | 4.82B |
| Mesoblast | 2.64B |